Affiliations 

  • 1 The Leeds Bionanotechnology Group, School of Biomedical Sciences, University of Leeds, LS2 9JT, Leeds, United Kingdom; Department of Pathology, School of Medical Sciences, Health Campus, Universiti Sains Malaysia, 16150, Kelantan, Malaysia. Electronic address: shazana.hilda@usm.my
  • 2 The Leeds Bionanotechnology Group, School of Biomedical Sciences, University of Leeds, LS2 9JT, Leeds, United Kingdom
  • 3 Astbury Centre for Structural and Molecular Biology, University of Leeds, LS2 9JT, Leeds, United Kingdom
  • 4 Leeds Institute of Medical Research, University of Leeds, LS9 7TF, Leeds, United Kingdom
  • 5 The Leeds Bionanotechnology Group, School of Biomedical Sciences, University of Leeds, LS2 9JT, Leeds, United Kingdom. Electronic address: P.A.Millner@leeds.ac.uk
Biosens Bioelectron, 2021 Apr 15;178:113013.
PMID: 33508539 DOI: 10.1016/j.bios.2021.113013

Abstract

Polyoctopamine (POct), an amine-functionalised non-conducting polymer, as the transducer layer in an electrochemical biosensor, is presented. This polymer offers versatile covalent coupling either through thiol linker conjugation, carboxyl or aldehyde functional groups without the requirement of pre- or post-surface activation. The colorectal cancer biomarker carcinoembryonic antigen (CEA) was selected as the target analyte, whilst an antibody and a synthetic binding protein, an Affimer, were used as distinct bioreceptors to demonstrate the versatility of polyoctopamine as a transducer polymer layer for oriented immobilisation of the bioreceptors. The electrodeposited polymer layer was characterised using cyclic voltammetry, electrochemical impedance spectroscopy, and on-sensor chemiluminescent blotting. The performance of optimised POct-based biosensors were tested in spiked human serum. Results showed that the electropolymerisation of octopamine on screen printed gold electrode generates a thin polymer film with low resistance. Close proximity of the immobilised bioreceptors to the transducer layer greatly enhanced the sensitivity detection. The sensitivity of the smaller monomeric bioreceptor (Affimer, 12.6 kDa) to detect CEA was comparable to the dimeric antibody (150 kDa) with limit of detection at 11.76 fM which is significantly lower than the basal clinical levels of 25 pM. However, the Affimer-based sensor had a narrower dynamic range compared to the immunosensor (1-100 fM vs. 1 fM - 100 nM, respectively). All electrochemical measurements were done in less than 5 min with small sample volumes (10 μl). Hence, polyoctopamine features a simple fabrication of impedimetric biosensors using amine-functionalisation technique, provides rapid response time with enhanced sensitivity and label-free detection.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.